Overview

Efficacy and Safety of Gabapentin/B-complex Versus Pregabalin in Diabetic Peripheral Neuropathy Pain Management

Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, randomized, open-label, parallel, Phase 4 clinical trial to compare efficacy and safety of gabapentin/B-complex versus pregabalin in diabetic peripheral neuropathy pain (DPNP) management.
Phase:
Phase 4
Details
Lead Sponsor:
Merck KGaA
Merck KGaA, Darmstadt, Germany
Collaborator:
Merck S.A. de C.V., Mexico
Treatments:
Gabapentin
gamma-Aminobutyric Acid
Pregabalin